Tag: biologic drug switch

Switching from an originator biologic to a biosimilar is safe for most patients with stable chronic conditions. Evidence shows no meaningful difference in efficacy or safety, though psychological factors can affect perception. Cost savings are significant, and structured patient communication improves outcomes.

Recent-posts

Osteoporosis: Understanding Bone Density Loss and How Bisphosphonates Help

Mar, 5 2026

How to Report Side Effects after Switching to a Generic Medication

Jan, 15 2026

Medication Alternatives: What to Do During a Shortage

Nov, 7 2025

ACE Inhibitors and High-Potassium Foods: What You Need to Know

Feb, 13 2026

Medication Safety for Non-English Speakers: How to Get Clear, Accurate Instructions

Jan, 30 2026